APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 73 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,719,000 | +30.0% | 383,538 | 0.0% | 0.91% | +22.1% |
| Q1 2019 | $7,479,000 | -35.2% | 383,538 | -56.1% | 0.75% | -49.4% |
| Q4 2018 | $11,536,000 | -52.1% | 874,573 | -35.4% | 1.47% | -39.3% |
| Q3 2018 | $24,084,000 | -24.8% | 1,354,554 | -7.0% | 2.43% | -41.2% |
| Q2 2018 | $32,043,000 | -0.6% | 1,456,499 | -0.1% | 4.13% | -9.6% |
| Q1 2018 | $32,233,000 | +1.9% | 1,457,834 | 0.0% | 4.57% | -32.6% |
| Q4 2017 | $31,635,000 | – | 1,457,834 | – | 6.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |